4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
4D Molecular Therapeutics (FDMT) - Net assets
Net assets on the balance sheet as of December 2023 : $0.30 B
According to 4D Molecular Therapeutics's latest financial reports the company has $0.30 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
4D Molecular Therapeutics - Net assets on balance sheet (from 2018 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.30 B | 33.07% |
| 2022-12-31 | $0.23 B | -27.5% |
| 2021-12-31 | $0.31 B | 24.46% |
| 2020-12-31 | $0.25 B | -451.36% |
| 2019-12-31 | $-72.97 M | 164.51% |
| 2018-12-31 | $-27.59 M | 40.82% |
| 2017-12-31 | $-19.59 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -27.20% | 🇺🇸 USA |